Cargando…

Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes

BACKGROUND: This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction. METHODS: From January 2005 to December 2016, the profiles of patients with degenerative MR who underwent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Zhao, Yun, Zhou, Tianyu, Wang, Yongshi, Zhu, Kai, Zhai, Junyu, Sun, Yongxin, Lai, Hao, Wang, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528233/
https://www.ncbi.nlm.nih.gov/pubmed/33004041
http://dx.doi.org/10.1186/s13019-020-01309-6
_version_ 1783589219085582336
author Li, Jun
Zhao, Yun
Zhou, Tianyu
Wang, Yongshi
Zhu, Kai
Zhai, Junyu
Sun, Yongxin
Lai, Hao
Wang, Chunsheng
author_facet Li, Jun
Zhao, Yun
Zhou, Tianyu
Wang, Yongshi
Zhu, Kai
Zhai, Junyu
Sun, Yongxin
Lai, Hao
Wang, Chunsheng
author_sort Li, Jun
collection PubMed
description BACKGROUND: This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction. METHODS: From January 2005 to December 2016, the profiles of patients with degenerative MR who underwent mitral valve repair at our institution were analyzed. Left ventricular systolic dysfunction was defined as an ejection fraction < 60% or left ventricular end-systolic dimension > 40 mm. Finally, 322 patients with left ventricular systolic dysfunction were included in this study. The prognosis of left ventricular function during follow-up was evaluated and preoperative factors associated with deteriorated left ventricular systolic function during follow-up were analyzed. RESULTS: The in-hospital mortality rate was 1.6%. The rate of eight-year overall survival, freedom from reoperation for mitral valve and freedom from recurrent MR were 96.9, 91.2 and 73.4%, respectively. Intraoperative residual mild MR (hazard ratio 4.82) and an isolated anterior leaflet lesion (hazard ratio 2.48) were independent predictive factors for recurrent MR. During follow-up, 212 patients underwent echocardiography examinations at our institution. Among them, 132 patients had improved left ventricular systolic function, and 80 patients had deteriorated left ventricular systolic. Freedom from recurrent MR was found in 75.9% of the improved left ventricular systolic function group and 56.2% of the deteriorated left ventricular systolic function group (P = 0.047). An age > 50 years (odds ratio 2.40), ejection fraction≤52% (odds ratio 2.79) and left ventricular end-systolic dimension≥45 mm (odds ratio 2.31) were independent risk factors for deteriorated left ventricular systolic function during follow-up. CONCLUSIONS: Mitral valve repair could be safely performed for degenerative MR in patients with left ventricular systolic dysfunction. Intraoperative residual mild MR and an isolated anterior leaflet lesion were independent predictive factors for recurrent MR. An age > 50 years, ejection fraction≤52% and left ventricular end-systolic dimension≥45 mm were independent risk factors for deteriorated left ventricular systolic function during follow-up.
format Online
Article
Text
id pubmed-7528233
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75282332020-10-01 Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes Li, Jun Zhao, Yun Zhou, Tianyu Wang, Yongshi Zhu, Kai Zhai, Junyu Sun, Yongxin Lai, Hao Wang, Chunsheng J Cardiothorac Surg Research Article BACKGROUND: This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction. METHODS: From January 2005 to December 2016, the profiles of patients with degenerative MR who underwent mitral valve repair at our institution were analyzed. Left ventricular systolic dysfunction was defined as an ejection fraction < 60% or left ventricular end-systolic dimension > 40 mm. Finally, 322 patients with left ventricular systolic dysfunction were included in this study. The prognosis of left ventricular function during follow-up was evaluated and preoperative factors associated with deteriorated left ventricular systolic function during follow-up were analyzed. RESULTS: The in-hospital mortality rate was 1.6%. The rate of eight-year overall survival, freedom from reoperation for mitral valve and freedom from recurrent MR were 96.9, 91.2 and 73.4%, respectively. Intraoperative residual mild MR (hazard ratio 4.82) and an isolated anterior leaflet lesion (hazard ratio 2.48) were independent predictive factors for recurrent MR. During follow-up, 212 patients underwent echocardiography examinations at our institution. Among them, 132 patients had improved left ventricular systolic function, and 80 patients had deteriorated left ventricular systolic. Freedom from recurrent MR was found in 75.9% of the improved left ventricular systolic function group and 56.2% of the deteriorated left ventricular systolic function group (P = 0.047). An age > 50 years (odds ratio 2.40), ejection fraction≤52% (odds ratio 2.79) and left ventricular end-systolic dimension≥45 mm (odds ratio 2.31) were independent risk factors for deteriorated left ventricular systolic function during follow-up. CONCLUSIONS: Mitral valve repair could be safely performed for degenerative MR in patients with left ventricular systolic dysfunction. Intraoperative residual mild MR and an isolated anterior leaflet lesion were independent predictive factors for recurrent MR. An age > 50 years, ejection fraction≤52% and left ventricular end-systolic dimension≥45 mm were independent risk factors for deteriorated left ventricular systolic function during follow-up. BioMed Central 2020-10-01 /pmc/articles/PMC7528233/ /pubmed/33004041 http://dx.doi.org/10.1186/s13019-020-01309-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Jun
Zhao, Yun
Zhou, Tianyu
Wang, Yongshi
Zhu, Kai
Zhai, Junyu
Sun, Yongxin
Lai, Hao
Wang, Chunsheng
Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title_full Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title_fullStr Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title_full_unstemmed Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title_short Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
title_sort mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction: early and mid-term outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528233/
https://www.ncbi.nlm.nih.gov/pubmed/33004041
http://dx.doi.org/10.1186/s13019-020-01309-6
work_keys_str_mv AT lijun mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT zhaoyun mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT zhoutianyu mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT wangyongshi mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT zhukai mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT zhaijunyu mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT sunyongxin mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT laihao mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes
AT wangchunsheng mitralvalverepairfordegenerativemitralregurgitationinpatientswithleftventricularsystolicdysfunctionearlyandmidtermoutcomes